HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice.

Abstract
Aldose reductase (AR), the first enzyme in the polyol pathway, has been implicated in a wide variety of physiological and pathological functions, such as diabetic vascular and neural complications. It is known that diabetes mellitus can exacerbate brain and retina damage after ischemic injuries. However, the underlying mechanisms are not clear. In the present study, we made use of db/db mice with an AR null mutation (AR(-/-)db/db) to understand better the role of AR in the pathogenesis of brain and retina ischemic injuries under diabetic conditions. Cerebral and retinal ischemia was induced by transient middle cerebral artery occlusion in control and diabetic mice either with or without an AR null mutation. Mice were evaluated for neurological deficits after 30 min of ischemia and 23.5 hr of reperfusion. Our results showed that the diabetic db/db mice had significantly more severe neurological deficit and larger brain infarct size than the nondiabetic mice. Compared with wild-type db/db mice, the AR(-/-)db/db mice had significantly lower neurological scores, smaller brain infarct areas, and less hemispheric brain swelling. Retinal swelling was also significantly decreased in the AR(-/-)db/db mice. Less swelling in the brain and retina of the AR(-/-)db/db mice correlated with less expression of the water channel aquaporin 4. Taken together, these data clearly show that deletion of AR leads to less severe brain and retinal ischemic injuries in the diabetic db/db mouse. The present study indicates that inhibition of AR in diabetics may protect against damage in the brain and retina following ischemic reperfusion injury.
AuthorsChung-Man Yeung, Amy C Y Lo, Alvin K H Cheung, Stephen S M Chung, David Wong, Sookja K Chung
JournalJournal of neuroscience research (J Neurosci Res) Vol. 88 Issue 9 Pg. 2026-34 (Jul 2010) ISSN: 1097-4547 [Electronic] United States
PMID20143423 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aqp4 protein, mouse
  • Aquaporin 4
  • Blood Glucose
  • Aldehyde Reductase
Topics
  • Aldehyde Reductase (deficiency, genetics, metabolism)
  • Animals
  • Aquaporin 4 (metabolism)
  • Blood Glucose (metabolism)
  • Brain (enzymology, metabolism, pathology)
  • Brain Ischemia (enzymology, metabolism, pathology)
  • Diabetes Mellitus, Experimental (enzymology, metabolism, pathology)
  • Diabetes Mellitus, Type 2 (complications, enzymology, metabolism, pathology)
  • Infarction, Middle Cerebral Artery (enzymology, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Oxidative Stress (physiology)
  • Retina (enzymology, metabolism, pathology)
  • Retinal Diseases (enzymology, metabolism, pathology)
  • Severity of Illness Index
  • Stroke (enzymology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: